tbuckley/cabot-search huggingface dataset:
Fibrosis-4 score less than 2.67 and normal gamma-glutamyl transferase levels are associated with high negative predictive value for high-risk of liver stiffness in patients with primary biliary cholangitis
Authors: Alan Bonder, Vilas Patwardhan, Joanna MacEwan, Anran Shao Shao, Leona Bessonova, Erik Ness, Tracy Mayne, Darren Wheeler, Radhika Nair, Jing Li, Shari Orbach
Journal: Journal of Hepatology (2023)
Hepatocellular carcinoma surveillance improves early detection and curative treatment in chronic hepatitis C patients treated with direct acting antivirals
Authors: Cassia Regina Guedes Leal, Carmem Ferguson Theodoro, Thais Guaraná, Jorge Strogoff-de-Matos, Rosângela Teixeira, Renata Perez, Paulo de Tarso Aparecida Pinto, Tatiana Guimaraes, Solange Artimos
Journal: Journal of Hepatology (2023)
Non-alcoholic fatty liver disease awareness, misperception, and their association with healthcare access in Korean general population: a nationally representative survey
Authors: Jun-Hyuk Lee, Eileen Yoon, Dae Won Jun, Sang Bong Ahn, Joo Hyun Oh, Hyunwoo Oh, Hyo Young Lee, Jihyun An, Joo Hyun Sohn, Eun Chul Jang
Journal: Journal of Hepatology (2023)
Comparison of clinical outcome between Nivolumab and Regorafenib as second-line systemic therapy after Sorafenib failure in patients with advanced hepatocellular carcinoma
Authors: Jae Seung Lee, Hong Jun Lee, Hye Won Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Do Young Kim
Journal: Journal of Hepatology (2023)
Digital pathology with artificial intelligence analyses provides deeper insights into lifestyle intervention-induced fibrosis regression in NASH
Authors: Haiyang Yuan, Yayun Ren, Yangyang Li, Xinlei Wang, Sui-Dan Chen, Xiao-Zhi Jin, Fa-Ling Wu, Xiao-Yan Pan, Wen-Yue Liu, Xiaodong Wang, Ming-Hua Zheng
Journal: Journal of Hepatology (2023)
The safety and efficacy of hepalatide (L47) treatment combined with pegylated interferon-alpha 2a in patients with chronic hepatitis B: the preliminary data from a double-blind, RCT phase II trial
Authors: Junliang Fu, Qing Mao, Qinglong Jin, Hui Cheng, Yongqian Cheng, Xiaolu Tang, Hongli Liu, Fu-Sheng Wang
Journal: Journal of Hepatology (2023)
Correlation between severity of hepatic steatosis and markers of cardiometabolic health, and effect of lanifibranor therapy in patients with non-cirrhotic NASH
Authors: Michael Cooreman, Sven Francque, Philippe Huot-Marchand, Lucile Dzen, Martine Baudin, Jean-Louis Junien, Pierre Broqua, Manal Abdelmalek
Journal: Journal of Hepatology (2023)
Predicting severe liver outcomes in NAFLD using repeated measurements of biomarkers—a cohort study in 1,260 patients
Authors: Ying Shang, Camilla Akbari, Maja Dodd, Xiao Zhang, Tongtong Wang, Thomas Jemielita, Gail Fernandes, Samuel Engel, Patrik Nasr, Johan Vessby, Fredrik Rorsman, Stergios Kechagias, Per Stal, Mattias Ekstedt, Hannes Hagström
Journal: Journal of Hepatology (2023)
A stepwise screening approach using non-invasive tests to identify phenotypic non-alcoholic steatohepatitis (NASH) patients with fibrosis for clinical trials
Authors: Naim Alkhouri, Rohit Loomba, Mazen Noureddin, Eric Lawitz, Kris Kowdley, Hiba Graham, Erin Quirk, Diana Chung
Journal: Journal of Hepatology (2023)
Impact of rifaximin use post-discharge of an overt hepatic encephalopathy (OHE) hospitalization on the annual rates of OHE-related inpatient stays
Authors: Arun Jesudian, Patrick Gagnon-Sanschagrin, Zeev Heimanson, Rebecca Bungay, Jingyi Chen, Annie Guérin, Ankur Dashputre, Brock Bumpass, Danellys Borroto, George Joseph
Journal: Journal of Hepatology (2023)
Preliminary safety and antiviral activity of AB-729 combination treatment with pegylated interferon alfa-2a in virally suppressed, HBeAg-negative subjects with chronic HBV infection
Authors: Man-Fung Yuen, Jeong Heo, Ronald G Nahass, Grace Lai-Hung Wong, Tatiana Burda, Kalyan Ram Bhamidimarri, Tsung-Hui Hu, Tuan Nguyen, Young-Suk Lim, Chi-Yi Chen, Stuart C Gordon, Jacinta Holmes, Wan-Long Chuang, Anita Kohli, Naim Alkhouri, Kevin Gray, Emily P. Thi, Elina Medvedeva, Timothy Eley, Karen Sims
Journal: Journal of Hepatology (2023)
Targeting the E2F/MCM axis in cholangiocarcinoma halts disease progression in experimental models by rewiring lipid metabolism
Authors: Mikel Ruiz de Gauna, Ane Nieva-Zuluaga, Maider Apodaka-Biguri, Francisco González-Romero, Nerea Muñoz-Llanes, Paul Gomez-Jauregui, Natalia Sainz-Ramírez, Kendall Alfaro-Jiménez, Beatriz Gómez Santos, Xabier Buque, Igor Aurrekoetxea, Igotz Delgado, Idoia Fernández-Puertas, Ainhoa Iglesias, Pedro Miguel Rodrigues, Diego Calvisi, Ana Zubiaga, Jesus Maria Banales, Patricia Aspichueta
Journal: Journal of Hepatology (2023)
Booster SARS-CoV-2 vaccination elicits robust antibody response to wild type but not Omicron subvariants BA.4/5 in patients with cirrhosis
Authors: Qian Zhu, Lu Wang, Xiaoxiao Hu, Dejuan Xiang, Ming-Li Peng, Dachuan Cai, Xiaofeng Shi, Hong Ren
Journal: Journal of Hepatology (2023)
Cyclophilin inhibition exhibits preventive and curative antifibrotic effects via extracellular matrix remodelling
Authors: Sara Campinoti, Una Rastovic, Lai Wei, Nicola Harris, Bruna Almeida, Omolola Ajayi, Caoimhe Kerins, Fiona Kenny, Sandra Phillips, Ane Zamalloa, Rosa Miquel, Yoh Zen, Krishna Menon, Eileen Gentleman, Tanya Shaw, Nigel Heaton, Daren Ure, Shilpa Chokshi, Luca Urbani, Elena Palma
Journal: Journal of Hepatology (2023)
Rapid functional secretome analysis of HBV-specific T cells to guide clinical management of CHB patients
Authors: Nina Le Bert, Apostolos Koffas, Anthony Tan, Lung-Yi Mak, Sophie Stretch, Shou Kit Hang, Haiyan Ma, Ariel Lee, Yun Ji, Upkar Gill, Qi Chen, Qing Zhu, Antonio Bertoletti, Patrick Kennedy
Journal: Journal of Hepatology (2023)
Clinical profile and outcomes of hepatocellular carcinoma in primary Budd Chiari syndrome
Authors: Ankit Agarwal, Sagnik Biswas, Manas Vaishnav, Shekhar Swaroop, Rithvik Golla, Shubham Mehta, Shivanand Gamangatti, Subrata Acharya, Sashi Paul, None Shalimar
Journal: Journal of Hepatology (2023)
Performance of non-invasive fibrosis tests for long-term liver and heart outcomes in Europeans with metabolic risk factors from the UK Biobank
Authors: Federica Tavaglione, Antonio De Vincentis, Oveis Jamialahmadi, Raffaele Antonelli Incalzi, Antonio Picardi, Stefano Romeo, Umberto Vespasiani Gentilucci
Journal: Journal of Hepatology (2023)
D-Mongolia: new strategy for hepatitis B, D and C screening and linkage to care in Mongolians living in Spain
Authors: Adriana Palom, Edurne Almandoz, Antonio Madejón, Ariadna Rando-Segura, Ylenia Pérez Castaño, Judit Vico-Romero, Naranbaatar Battulga, Mar Riveiro Barciela, Jordi Gómez-Prat, Juan Ignacio Arenas, Francisco Javier Garcia-Samaniego Rey, Maria Buti
Journal: Journal of Hepatology (2023)
Diabetes mellitus (DM) is the strongest risk factor of significant inflammation or fibrosis in chronic hepatitis B (CHB) combined with non-alcoholic fatty liver disease (NAFLD)
Authors: Jie Li, Fajuan Rui, Brian Nguyen, Chuanwu Zhu, Yuanwang Qiu, Weimao Ding, Qi Zheng, Qing-Lei Zeng, Zebao He, Junping Shi, Chao Wu, Mindie Nguyen
Journal: Journal of Hepatology (2023)
Serum exosomal mir-4668-5p in Non-alcoholic Fatty liver Disease (NAFLD) patients with significant liver fibrosis
Authors: Jong Eun Yeon, Young-Sun Lee, Eunjung Ko, Yoonseok Lee, Sun Young Yim, Young Kul Jung, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim
Journal: Journal of Hepatology (2023)
Relationship of hepcidin levels to metabolic factors, anthropometric indicators of adiposity and disease severity in NAFLD patients
Authors: Claudia Cravo, Cristiane Villela-Nogueira, Ana Carolina Cardoso, Fernanda Calçado, Guilherme Rezende, Frederico Campos Ferreira, Joao Marcello de Araujo Neto, Jorge Eduardo Pinto, Henrique Sergio Coelho, Renata Perez, Nathalie Leite
Journal: Journal of Hepatology (2023)
Intermittent fasting improves tumor-directed drug delivery by caveolar-mediated endocytosis
Authors: Svea Becker, Ilaria Biancacci, Diana Möckel, Qingbi Wang, Jan-Niklas May, Huan Su, Jeffrey Momoh, Lena Susanna Candels, Marie-Luise Berres, Fabian Kiessling, Maximilian Hatting, Twan Lammers, Christian Trautwein
Journal: Journal of Hepatology (2023)
Outcomes between surgical resection and transarterial chemoembolization in patients with multifocal BCLC-A and Child-Pugh B
Authors: Ji won Yang, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jonggi Choi
Journal: Journal of Hepatology (2023)
High diagnostic uptake of a targeted panel sequencing in adult patients with chronic hereditary liver disorders
Authors: Luisa Ronzoni, Ilaria Marini, Serena Pelusi, Federica Golfetto, Angela Lombardi, Jessica Rondena, Giulia Periti, Cristiana Bianco, Giulia Passignani, Roberta D’Ambrosio, Daniele Prati, Luca Valenti
Journal: Journal of Hepatology (2023)
Positive effects of PARP-1 inhibition in KRAS-mutated intrahepatic cholangiocarcinoma is mediated by CHK1 kinase
Authors: Darko Castven, Friederike Keggenhoff, Stojan Stojkovic, Diana Becker, Jovana Castven, Carolin Zimpel, Beate Straub, Harald Langer, Patrizia Hähnel, Thomas Kindler, Jörg Fahrer, Colm O Rourke, Lichun Ma, Xin W. Wang, Timo Gaiser, Matthias Matter, Christian Sina, Stefanie Derer, Stephanie Roessler, Bernd Kaina, Jesper Andersen, Peter Galle, Jens Marquardt
Journal: Journal of Hepatology (2023)
Diagnostic performance of NAFLD fibrosis score in lean NAFLD
Authors: Huiyul Park, Eileen Yoon, Sang Bong Ahn, Hye-Lin Kim, Jun-Hyuk Lee, Mimi Kim, Chul-min Lee, Bo-Kyeong Kang, Joo Hyun Sohn, Jihyun An, Joo Hyun Oh, Hyo Young Lee, Hyunwoo Oh, Jang Han Jung, Dae Won Jun, Eun Chul Jang
Journal: Journal of Hepatology (2023)
Quality of life in patients with unresectable hepatocellular carcinoma treated with selective internal radiation therapy (SIRT) and Nivolumab: a sub-analysis of the NASIR-HCC trial
Authors: Manuel de la Torre, Ana Matilla, Maria Varela, Mercedes Iñarrairaegui, María Reig, José Luis Lledó, Juan Ignacio Arenas Ruiz-Tapiador, Sara Lorente Perez, Milagros Testillano, Laura Marquez Perez, Gemma Iserte, Josep Maria Argemi, Carlos Gomez-Martin, Macarena Rodriguez-Fraile, Jose Ignacio Bilbao, Ion Agirrezabal, Bruno Sangro
Journal: Journal of Hepatology (2023)
Pasteurized Akkermansia muciniphila inhibits fibrosis progression in mouse cirrhosis model and induces changes in the gut microbiome
Authors: Sung-Min Won, Jin-Ju Jeong, Satya Priya Sharma, Raja Ganesan, Haripriya Gupta, Mi Ran Choi, Ki Kwang Oh, Young Lim Ham, Ki Tae Suk
Journal: Journal of Hepatology (2023)
Light cytokine-deficiency effects in inmune cells subpopulations in a murine non alcohol-related steatohepatitis model
Authors: María Aguilar Ballester, Elena Jiménez-Martí, Gema Hurtado-Genovés, Alida Taberner-Cortés, Ángela Vinué, Andrea Herrero-Cervera, Sergio Martínez-Hervás, Herminia González-Navarro
Journal: Journal of Hepatology (2023)
Patients with risk factors for liver diseases associated with hepatic steatosis constitute the target population for liver fibrosis assessment in primary care
Authors: Rosario Hernández, Jordi Hoyo, Marta Carol, Ruth Nadal, Adria Juanola, Anna Soria, Ana Belen Rubio Garcia, Marta Cervera, Martina Perez, Matilde Fuentes, Guillem Pera, Sara Martinez, Carla Chacon, Maria Sanchez, Aura Capdevila, Marife Alvarez, Jordi Gratacos, Pere Torán, Isabel Graupera, Elisa Pose, Alba Martínez-Escudé, Pere Ginès, Llorenç Caballeria, Núria Fabrellas
Journal: Journal of Hepatology (2023)
Significant fibrosis is a risk factor for worse health perception and impaired mental health in people living with HIV
Authors: Jesús Funuyet-Salas, Maurice Michel, María Angeles Pérez-San-Gregorio, Agustín Martín-Rodríguez, Manuel Romero Gomez, Peter Galle, Martin Sprinzl, Jörn Schattenberg
Journal: Journal of Hepatology (2023)
Health-related quality of life in a population at-risk of NAFLD or ArLD
Authors: Helle Lindholm Schnefeld, Katrine Prier Lindvig, Anita Arslanow, Isabel Graupera, Maria Kjærgaard, Katrine Thorhauge, Johanne Kragh Hansen, Camilla Dalby Hansen, Stine Johansen, Mads Israelsen, Peter Andersen, Nikolaj Torp, Katrine Bech, Sönke Detlefsen, Núria Fabrellas, Pere Ginès, Aleksander Krag, Maja Thiele
Journal: Journal of Hepatology (2023)
Cholestatic liver disease is alleviated by colitis-induced inhibition of bile acid synthesis
Authors: Wenfang Gui, Mikal Jacob Hole, Antonio Molinaro, Karolina Edlund, Kristin K. Jørgensen, Huan Su, Brigitte Begher-Tibbe, Nikolaus Gaßler, Carolin V. Schneider, Uthayakumar Muthukumarasamy, Antje Mohs, Lijun Liao, Julius Jäger, Christian Mertens, Ina Bergheim, Till Strowig, Jan G. Hengstler, Johannes R. Hov, Hanns-Ulrich Marschall, Christian Trautwein, Kai Markus Schneider
Journal: Journal of Hepatology (2023)
Baseline characteristics and risk profiles of 1111 patients with primary biliary cholangitis (PBC) in need of second-line therapy
Authors: Gideon Hirschfield, Kris Kowdley, Andreas E. Kremer, John M. Vierling, Christopher Bowlus, Cynthia Levy, Marlyn J. Mayo, Daria B. Crittenden, Mary Standen, Ke Yang, Yun-Jung Choi, Charles McWherter
Journal: Journal of Hepatology (2023)
A novel web-based online nomogram to predict advanced liver fibrosis in patients with autoimmune hepatitis-primary biliary cholangitis overlap syndrome
Authors: Zhiyi Zhang, Jian Wang, Yun Chen, Yiguang Li, Li Zhu, Huali Wang, Yilin Liu, Chuanwu Zhu, Jie Li, Rui Huang, Chao Wu, Yuanwang Qiu
Journal: Journal of Hepatology (2023)
Dynamic evolution of the serum metabolome reflects human hepatocarcinogenesis
Authors: Johann von Felden, Tim Rose, Lorenz Adlung, Manuela Peschka, Thorben Fruendt, Ismail Labgaa, Philipp Haber, Carolin Zimpel, Darko Castven, Arndt Weinmann, Teresa Garcia-Lezana, Moritz Waldmann, Thomas Renne, Hannah Voß, Manuela Moritz, Dorian Orlikowski, Helmut Schlüter, Myron Schwartz, Jan Baumbach, Ansgar W. Lohse, Samuel Huber, Henning Wege, Jens Marquardt, Augusto Villanueva, Josch Pauling, Kornelius Schulze
Journal: Journal of Hepatology (2023)
Cost effectiveness analysis of screening for advanced hepatic fibrosis in patients with various ‘at-risk population’ in guidelines
Authors: Hye-Lin Kim, Huiyul Park, Hyo Young Lee, Eileen Yoon, Mimi Kim, Sang Bong Ahn, Chul-min Lee, Bo-Kyeong Kang, Joo Hyun Sohn, Jihyun An, Joo Hyun Oh, Dae Won Jun, Eun Chul Jang
Journal: Journal of Hepatology (2023)
A radiogenomics study for hepatocellular carcinoma: distinct transcriptome patterns underlying different radiomics phenotypes in early recurrence
Authors: Weijia Liao, Liying Ren, Dongbo Chen, Tingfeng Xu, Bigeng Zhao, Zhipeng Zhou, Yong He, Junxiong Yu, Minjun Liao, Hongsong Chen
Journal: Journal of Hepatology (2023)
A diagnostic non-invasive model for liver advanced fibrosis and cirrhosis in chronic hepatitis B (CHB) concurrent with non-alcoholic fatty liver disease (NAFLD) based on machine learning (ML)
Authors: Jie Li, Yayun Xu, Fajuan Rui, Xiaorong Tian, Qi Xue, Qi Zheng, Qing-Lei Zeng, Zebao He, Jian Wang, Weimao Ding, Chuanwu Zhu, Yuanwang Qiu, Yunliang Chen, Junqing Fan, Junping Shi, Chao Wu
Journal: Journal of Hepatology (2023)
Effects of interferon-based therapies in functional cure and hepatocellular carcinoma risk reduction in patients with chronic hepatitis B: real-world evidence from 2-year data of OASIS project
Authors: Qiran Zhang, Feng Sun, Yiqi Yu, Tingting Zhao, Shulan Sui, Jiming Zhang, Jia Shang, Jiawei Geng, Yignli He, Ying Guo, Caiyan Zhao, Yueyong Zhu, Xuebing Yan, Wenhong Zhang
Journal: Journal of Hepatology (2023)
The performance of the cobas® HBV RNA assay for use on the cobas® 5800/6800/8800 Systems (RUO) against genomic variants and transcript heterogeneity
Authors: Thomas Meister, Victoria Innocent, Debra Liggett, Dax Javier, Alan Blair, Zih-Hua Chen, Abdellali Kelil, Sneha Nishtala, Caroline Scholtes, Barbara Testoni, Marie-Laure Plissonnier, Massimo Levrero, Fabien Zoulim, Marintha Heil, Aaron Hamilton
Journal: Journal of Hepatology (2023)
Efficacy of pemafibrate in patients with non-alcoholic fatty liver disease complicated by dyslipidemia: a single-arm prospective study
Authors: Hiroki Ono, Masanori Atsukawa, Kaori Koyano, Yuta Hasegawa, Tadamichi Kawano, Tomohide Tanabe, Yuji Yoshida, Tomomi Okubo, Taeang Arai, Korenobu Hayama, Norio Itokawa, Katsuhiko Iwakiri
Journal: Journal of Hepatology (2023)
Hepatitis E virus seroprevalence in immunosuppressed patients in Belgium: a prospective study
Authors: Marie Philippart, Michael Peeters, Hubert Piessevaux, Maria Badii, Sarah Bailly, Xavier Poiré, Nada Kanaan, Arnaud Devresse, Benoit Kabamba, Géraldine Dahlqvist
Journal: Journal of Hepatology (2023)
Validation of serum biomarker panels for early HCC detection: results from a large prospective European and Latin American multicenter study
Authors: Boris Beudeker, Siyu Fu, Domingo Balderramo, Angelo Z. Mattos, Enrique Carrera, Javier Diaz-Ferrer, Jhon Prieto, Marco Arrese, Arndt Vogel, Jesus Maria Banales, Jeffrey Oliveira, Anthony Grooshuismink, Gertine Oord, Robert De Man, Jose Debes, Andre Boonstra
Journal: Journal of Hepatology (2023)
PD1-negative CD45RA effector-memory CD8 T-cells are essential for response to checkpoint inhibition in advanced hepatocellular carcinoma
Authors: Sarah Cappuyns, Gino Philips, Vincent Vandecaveye, Bram Boeckx, Rogier Schepers, Thomas Van Brussel, Ingrid Arijs, Aurelie Mechels, Ayse Bassez, Francesca Lodi, Joris Jaekers, Halit Topal, Baki Topal, Orian Bricard, Junbin Qian, Eric Van Cutsem, Chris Verslype, Diether Lambrechts, Jeroen Dekervel
Journal: Journal of Hepatology (2023)
Deciphering the cellular and molecular determinants of immunotherapy resistance in NASH-associated hepatocellular carcinoma by single-cell analysis
Authors: Lingyun Zhang, Yiling Zhang, Wenshu Tang, Zhewen Xiong, Xiaoyu Liu, Zhixian Liang, Weiqin Yang, Alfred Sze-Lok Cheng
Journal: Journal of Hepatology (2023)
Most vulnerable HCV patient groups treated with direct acting antivirals achieve high response rates and gain quality of life-data from the German hepatitis C-registry (DHC-R)
Authors: Stefan Christensen, Albrecht Stoehr, Gerlinde Teuber, Jörg Petersen, Ralph Link, Uwe Naumann, Christine John, Yvonne Serfert, Karl-Georg Simon, Stefan Zeuzem, Heiner Wedemeyer
Journal: Journal of Hepatology (2023)
A deep exploration of bridging fibrosis evolution and individual septa parameters in NASH using quantitative second harmonic generation imaging reveals fibrosis changes in natural history and treatment-induced not seen with conventional histology
Authors: Elaine Chng, Nikolai Naoumov, David E Kleiner, Dominique Brees, Chandra Saravanan, Yayun Ren, Dean Tai, Arun Sanyal
Journal: Journal of Hepatology (2023)
Association of tumor response with survival in patients with unresectable hepatocellular carcinoma treated with first-line tislelizumab versus sorafenib: results from the RATIONALE-301 study
Authors: Tim Meyer, Richard S. Finn, Masatoshi Kudo, Andrew X. Zhu, Songzi Li, Yaxi Chen, Frederic Boisserie, Ramil Abdrashitov, Arndt Vogel, Shukui Qin
Journal: Journal of Hepatology (2023)
Long-term efficacy and safety of odevixibat in patients with progressive familial intrahepatic cholestasis: results with 96 weeks or more of treatment
Authors: Richard Thompson, Ozlem Durmaz, Tassos Grammatikopoulos, Angelo Di Giorgio, Quanhong Ni, Philip Stein, Christine Clemson, Ekkehard Sturm
Journal: Journal of Hepatology (2023)
Distinct immunometabolic signatures in circulating immune cells define disease outcomes in acute-on-chronic liver failure
Authors: Rita Furtado Feio de Azevedo, Markus Boesch, Silvia Radenkovic, Marie Wallays, Lukas Van Melkebeke, Bram Boeckx, Gino Philips, Lena Smets, Wim Laleman, Philippe Meersseman, Alexander Wilmer, David Cassiman, Hannah Van Malenstein, Joan Clària, Frederik Nevens, Jef Verbeek, Richard Moreau, Vicente Arroyo, Dieter Lambrechts, Bart Ghesquière, Hannelie Korf, Schalk van der Merwe
Journal: Journal of Hepatology (2023)
Functional and mechanistic role of lncRNA-C1 in cholestatic liver diseases
Authors: Joan Blázquez Vicens, Alberto Tinahones Ruano, Jorge Cañas, Luigi Borzacchiello, Alba Capelo, Marcos Fernandez Fondevila, Begoña Porteiro, Mason Bunyan-Woodcraft, David Fernández Ramos, Maria Jesus Perugorria Montiel, Juan Carlos Garcia Pagan, Jesus Maria Banales, Piotr Milkiewicz, Małgorzata Milkiewicz, Bruno Sangro, Luis Bujanda, Matías A Avila, Ana María Aransay, José M. Mato, Juan Turnes, Beatriz Pelacho, Ruben Nogueiras, María Luz Martínez-Chantar, Ashwin Woodhoo, Marta Varela-Rey
Journal: Journal of Hepatology (2023)
Treatment monitoring with the Agile 3+ score in patients with non-alcoholic steatohepatitis: analysis of data from a randomised placebo-controlled trial of semaglutide
Authors: Laurent Castéra, Céline Fournier-Poizat, Julie Foucquier, Mette Kjaer, Niels Krarup, Véronique Miette, Sune Boris Nygård, Ahsan Shoeb Patel, Laurent Sandrin, Jörn Schattenberg
Journal: Journal of Hepatology (2023)
Efficacy and safety of celecoxib add on nucleos (t)ide analogues on the hepatitis B surface antigen of virally suppressed patients with chronic hepatitis B-interim analysis
Authors: Feng Xue, Yingying Li, Jing Zhang, Qing Ye, Huiying Rao, Zhenhuan Cao, Jun Li, Xiaohe Li, Lai Wei
Journal: Journal of Hepatology (2023)
Serum levels of type IV collagen 7S can predict liver-related mortality and events as well as advanced fibrosis: a multi-center study
Authors: Hiroshi Ishiba, Yoshio Sumida, Yoshihiro Kamada, Hideki Fujii, Michihiro Iwaki, Hideki Hayashi, Hidenori Toyoda, Satoshi Oeda, Hideyuki Hyogo, Miwa Kawanaka, Asahiro Morishita, Kensuke Munekage, Kazuhito Kawata, Tsubasa Tsutsumi, Koji Sawada, Tatsuji Maeshiro, Hiroshi Tobita, Yuichi Yoshida, Masafumi Naito, Shingo Araraki, Takumi Kawaguchi, Hiedenao Noritake, Masafumi Ono, Tsutomu Masaki, Satoshi Yasuda, Eiichi Tomita, Masato Yoneda, Akihiro Tokushige, Hirokazu Takahashi, Shinichiro Ueda, Atsushi Nakajima, Takeshi Okanoue
Journal: Journal of Hepatology (2023)
Liver stiffness measurements with a new point-of-care device, hepatoscope, using two-dimensional transient elastography showed both very good reproducibility and correlation to fibroscan
Authors: Victor de Lédinghen, Dan Dutartre, Françoise Manon, Joëlle Abiven, Anne-Laure de Araujo, Rhizlane Houmadi, Julie Dupuy, Juliette Foucher, Joel Gay, Claude Cohen-Bacrie
Journal: Journal of Hepatology (2023)
Biomarkers identifying hepatic inflammation in non-alcoholic fatty liver disease (NAFLD)
Authors: Mikkel Werge, Annabelle Hoegl, Marie Louise Therkelsen, Mads Grønborg, Gianluca Mazzoni, Lea Mørch Harder, Henning Hvid, Elias Rashu, Mira Thing, Liv Hetland, Anders Junker, Reza Serizawa, Mogens Vyberg, Elisabeth Galsgaard, Lise Lotte Gluud
Journal: Journal of Hepatology (2023)
Epigenetic modulation by DNA methyltransferase inhibition may enhance the effect of immune checkpoint inhibitors to restore HBV-specific T cell responses
Authors: Melanie Urbanek-Quaing, Carlos Oltmanns, Jasmin Mischke, Heiner Wedemeyer, Cheng-Jian Xu, Anke Kraft, Markus Cornberg
Journal: Journal of Hepatology (2023)
RBCK1 promotes the stabilization of HBx by linear ubiquitination to drive the progression of HBV-associated hepatocellular carcinoma
Authors: Zheyu Dong, Peng Chen, Yuxin Zhou, Qiuyue Ye, Junling Chen, Jianzhong Cai, Yiyan Huang, Jiayue Yang, Yaoting Feng, Liangxing Chen, Libo Tang, Yongyin Li
Journal: Journal of Hepatology (2023)
Beneficial effect of cystic fibrosis transmembrane conductance regulator modulators on adults with cystic fibrosis liver disease
Authors: Sofia Manioudaki, Larisa Vasilieva, Ilianna Mani, Filia Diamantea, Theodoros Alexopoulos, Sophia Pouriki, Zoe Athanassa, Aikaterini Sakagianni, Eleni Geladari, Ioannis Elefsiniotis, Emilia Hadziyannis, Alexandra Alexopoulou
Journal: Journal of Hepatology (2023)
Performance of non-invasive tests as exclusion criteria for cirrhosis in trials targeting at-risk non-alcoholic steatohepatitis: combined data from multiple trials including more than 5,000 patients (in collaboration with NAIL-NIT consortium)
Authors: Naim Alkhouri, Julie Dubourg, Stephen Harrison, Mazen Noureddin, Michael Charlton, Vlad Ratziu, Sophie Jeannin Megnien, Jörn Schattenberg
Journal: Journal of Hepatology (2023)